Data / Form D filings / Proteas Bioanalytics Inc.
Proteas Bioanalytics Inc.: Form D filings
Proteas Bioanalytics Inc., a technology company in Torrance, CA, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on March 13, 2023, reports $365,000 sold of a $3 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Biolabs at the Lundquist Institute, 1124 W. Carson St., MRL Building 3rd FL, Torrance, CA, 90502
- Phone
- (626) 200-7238
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1831825
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | New notice | $3,000,000 | $365,000 | $2,635,000 | 5 | Aug 11, 2022 | sec.gov |
| Nov 10, 2021 | Amendment | $4,000,000 | $1,420,000 | $2,580,000 | 7 | Oct 31, 2020 | sec.gov |
| Nov 9, 2020 | New notice | $4,000,000 | $365,000 | $3,635,000 | 3 | Oct 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Valerie Darling | Director | |
| Spiros Garbis | Executive Officer, Director | |
| Antigoni Manousopoulou | Director |
Other technology companies in California that filed recently
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
- TrashLab Software Inc. $10.7 million · Oct 29, 2026
- Vasopore, Inc. $1.1 million · Oct 28, 2026
Every Form D from the week of Mar 13, 2023 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Proteas Bioanalytics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.